Browsing by Author Taylor, B A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2010Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trialChalmers, John; Neal, Bruce; Patel, Anushka; Woodward, Mark; Batty, G. David; Czernichow, Sebastien; de Galan, B; Li, Q; Poulter, Neil; Taylor, B A; Zoungas, Sophia; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthOral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial, Diabetologia: clinical and experimental diabetes and metabolism, vol.53, 11,pp 2320-2327
2013Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trialBatty, G. David; Chalmers, John; Colagiuri, Stephen; de Galan, Bastiaan; Huxley, Rachel; Li, Qiang; Neal, Bruce; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Harrap, Stephen B.; Taylor, B A; The George Institute for Global Health; The George Institute for Global Health; Central Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthOral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial, European Psychiatry, vol.28, 1, 2013,pp 49-52